Vinod Bansal

2.0k total citations
72 papers, 1.1k citations indexed

About

Vinod Bansal is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vinod Bansal has authored 72 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Nephrology, 18 papers in Cardiology and Cardiovascular Medicine and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vinod Bansal's work include Dialysis and Renal Disease Management (22 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Erythropoietin and Anemia Treatment (9 papers). Vinod Bansal is often cited by papers focused on Dialysis and Renal Disease Management (22 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Erythropoietin and Anemia Treatment (9 papers). Vinod Bansal collaborates with scholars based in United States, Spain and Switzerland. Vinod Bansal's co-authors include Judith A. Beto, Jawed Fareed, Debra Hoppensteadt, Jessie E. Hano, Gregory A. Kozeny, Leonard L. Vertuno, Anthony L. Barbato, Holly Kramer, Kavitha Vellanki and Seema Bansal and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Vinod Bansal

70 papers receiving 1.1k citations

Peers

Countries citing papers authored by Vinod Bansal

Since Specialization

Citations

This map shows the geographic impact of Vinod Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinod Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinod Bansal more than expected).

Fields of papers citing papers by Vinod Bansal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinod Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinod Bansal. The network helps show where Vinod Bansal may publish in the future.

Co-authorship network of co-authors of Vinod Bansal

This figure shows the co-authorship network connecting the top 25 collaborators of Vinod Bansal. A scholar is included among the top collaborators of Vinod Bansal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinod Bansal. Vinod Bansal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure 2024 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), Vinod Bansal, Fakiha Siddiqui, (unknown), Debra Hoppensteadt, (unknown), (unknown), (unknown), Jawed Fareed, Mushabbar Syed	1
2	Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients With End-Stage Renal Disease 2024 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), Debra Hoppensteadt, Fakiha Siddiqui, Jawed Fareed, Vinod Bansal	0
3	Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress 2024 ·Diagnostics ·(unknown), Branislava Medić, Katarina Savić Vujović, Ivana Ćirković, (unknown), (unknown), Omer Iqbal, (unknown), Jawed Fareed, Vinod Bansal	1
4	Angiopoietin-2 and Mortality Outcomes in End-Stage Renal Disease with Heart Failure as a Comorbidity 2024 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), Vinod Bansal, Kavitha Vellanki, Fakiha Siddiqui, Debra Hoppensteadt, Jawed Fareed, Mushabbar Syed	2
5	The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients 2023 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), Vinod Bansal, Fakiha Siddiqui, Debra Hoppensteadt, (unknown), Jawed Fareed, (unknown)	3
6	#2724 THROMBO-INFLAMMATORY BIOMARKERS OF CARDIORENAL SYNDROME IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS IN END STAGE RENAL DISEASE 2023 ·Nephrology Dialysis Transplantation ·Vinod Bansal, (unknown), Jawed Fareed, Fakiha Siddiqui, Debra Hoppensteadt	1
7	Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method 2022 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), (unknown), Fakiha Siddiqui, (unknown), Debra Hoppensteadt, Vinod Bansal, Amir Darki, David H. Van Thiel, Jawed Fareed	3
8	Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States 2017 ·Circulation ·Adam P. Bress, Holly Kramer, Rasha Khatib, Srinivasan Beddhu, Alfred K. Cheung, Rachel Hess, Vinod Bansal, Guichan Cao, Jerry Yee, Andrew E. Moran, Ramón Durazo-Arvizú, Paul Muntner, Richard Cooper	76
9	Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures 2017 ·BMC Nephrology ·Christina Small, Holly Kramer, Karen A. Griffin, Kavitha Vellanki, David J. Leehey, Vinod Bansal, Talar Markossian	20
10	Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report 2017 ·American Journal of Kidney Diseases ·Vinod Bansal, Charles A. Herzog, Mark J. Sarnak, Michael Choi, Ravindra L. Mehta, Bernard G. Jaar, Michael V. Rocco, Holly Kramer	20
11	Urinary incontinence and diuretic avoidance among adults with chronic kidney disease 2016 ·International Urology and Nephrology ·Mitul Patel, Kavitha Vellanki, David J. Leehey, Vinod Bansal, Linda Brubaker, Robert C. Flanigan, (unknown), (unknown), Neelam Balasubramanian, Jasmin Sandhu, Holly Kramer	13
12	Neurologic Complications of Chronic Kidney Disease 2015 ·Current Neurology and Neuroscience Reports ·Kavitha Vellanki, Vinod Bansal	8
13	Nervous system disorders in dialysis patients 2013 ·Handbook of clinical neurology ·Vinod Bansal, Seema Bansal	24
14	Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease 2007 ·Clinical Therapeutics ·Anatole Besarab, Moro O. Salifu, N M Lunde, Vinod Bansal, Steven Fishbane, Frank C. Dougherty, Ulrich Beyer	32
15	Medical nutrition therapy in chronic kidney failure: Integrating clinical practice guidelines 2004 ·Journal of the American Dietetic Association ·Judith A. Beto, Vinod Bansal	75
16	The Effect of Blood Draw Methodology on Selected Nutritional Parameters in Chronic Renal Failure 1999 ·Advances in Renal Replacement Therapy ·Judith A. Beto, Vinod Bansal, (unknown)	2
17	Treatment of lupus nephritis: A meta-analysis of clinical trials 1997 ·American Journal of Kidney Diseases ·Vinod Bansal, Judith A. Beto	116
18	Central line perforation associated with Staphylococcus epidermidis infection 1993 ·Journal of Pediatric Surgery ·Vinod Bansal, Arthur Strauss, Michael T. Gyepes, (unknown)	9
19	Pharmacy Computer Prescription Databases: Methodologic Issues of Access and Confidentiality 1992 ·Annals of Pharmacotherapy ·Judith A. Beto, (unknown), (unknown), Vinod Bansal	8
20	Nuclear magnetic resonance studies of lithium transport in erythrocyte suspensions of hypertensives 1990 ·Clinica Chimica Acta ·Ravichandran Ramasamy, Duarte Mota de Freitas, Vinod Bansal, Elizabeth Dorus, Richard Labotka	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact